FLOWER-MI: FFR vs. Angiography for Complete Revascularization in Infarction

Functional assessment with fractional flow reserve (FFR) was not better than conventional angiography to guide complete revascularization in patients with multivessel lesions in a setting of ST-segment elevation myocardial infarction and successful primary angioplasty.

FLOWER-MI: FFR vs angiografía para revascularización completa en los infartos

These results were published in the New England Journal of Medicine (NEJM) and presented during the American College of Cardiology (ACC) 2021 Congress.

The rate of major cardiovascular events was low and similar between both strategies at a one-year follow-up. This would jeopardize the cost-benefit relationship of FFR in infarction.

Randomized and registry evidence is robust regarding FFR superiority vs. angiography in patients with chronic coronary syndromes.

In an acute context (especially in ST-segment elevation infarction), the COMPARE-ACUTE and DANAMI3-PRIMULTI studies showed that FFR-guided complete revascularization was superior to culprit-vessel angioplasty alone.

There is little information on FFR-guided complete revascularization vs. angiography-guided revascularization in ST-segment elevation infarction.

FLOWER-MI received some criticism from experts. On the one hand, the low incidence of events could take away some of its statistical power; on the other, non-culprit lesions seem particularly significant. In this sense, they do not appear to be typical intermediate lesions where FFR guide showed the greatest benefit.


Read also: Pfizer/BioNTech Vaccine against COVID-19 in Teenagers.


Another target of criticism was that operators performed the entire revascularization in the same procedure, something that is far from daily clinical practice.

These studies analyzed 1163 patients with acute myocardial infarction and multivessel lesion (mean age: 62.2 years) who underwent successful primary angioplasty in the culprit vessel randomized to FFR-guided vs. angiography-guided complete revascularization.

Angiography of non-culprit lesions was conducted in 66.2% of FFR-guided patients and in 97.1% of angiography-guided patients.


Read also: Myocarditis and Messenger RNA COVID-19 Vaccine: What Is the Risk?


The primary endpoint (a composite of death, infarction, or unplanned revascularization requiring hospitalization) was reached in 5.5% of patients the FFR arm vs. 4.2% in the angiography arm, a non-significant difference (hazard ratio: 1.32; 95% confidence interval: 0.78 to 2.23; p = 0.31). The statistics for the separate components of the primary endpoint were also similar, and so were the secondary endpoints (stent thrombosis, antianginal medication, quality of life, and readmissions).

nejmoa2104650

Original Title: Multivessel PCI Guided by FFR or Angiography for Myocardial Infarction. 

Reference: Etienne Puymirat et al. N Engl J Med. 2021 May 16. Online ahead of print. doi: 10.1056/NEJMoa2104650. The FLOWER-MI Study Investigators.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...

CRABBIS Trial: Comparison of Different Provisional Stenting Sequences

Provisional stenting (PS) is the gold standard for percutaneous coronary intervention (PCI) in most patients with coronary bifurcation lesions (CBL). Moreover, recent studies such...

Andromeda Trial: Meta-Analysis of Drug Coated Balloon vs. DES in Small Vessel DeNovo Lesions

The use of coronary stents vs plain old balloon angioplasty (POBA), has allowed to reduce recoil and limiting flow dissection which were major limitation...

QFR vs. FFR: Is Coronary Revascularization Deferral Safe? Results from a FAVOR III Sub-Analysis

In cases of intermediate coronary lesions, functional assessment is recommended to aid the decision-making process regarding revascularization. There are several tools currently used to...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...

ACC 2025 | API-CAT: Reduced vs. Full Dose Extended Anticoagulation in Patients with Cancer Related VTE

The risk of cancer related recurrent venous thromboembolism (VTE) will drop over time, while bleeding risk will persist. At present, it is recommended we...

STRIDE: Semaglutide in Patients with Peripheral Arterial Disease and Type II Diabetes

Peripheral arterial disease (PAD) is a severe complication in patients with type II diabetes, primarily affecting peripheral vessels, especially below-the-knee (BTK) arteries. This condition...